Form D · Venture Capital Fund
CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP
Newark, DE · CIK 0002035425
Offering snapshot reported Aug 28, 2024 · SEC filing
- Reported sold
- $130K Offering amount: $130K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Aug 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2024 | Initial | $129,974 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-522615
Source: Form D, filed Aug 28, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charly Kevers | Executive |
| Vauban Advisers Llc | Promoter |
| Vauban Capital Gp Llc | Promoter |
| Henry Shozen Ward | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
131 Continental Drive Suite 305
Newark, DE, 19713
Newark, DE, 19713